Search Results - I. Weitz
- Showing 1 - 13 results of 13
-
1
XI before X: The Promise of Factor XI Inhibitors by Jeffrey I. Weitz, Husam Alzayer
Published in Kidney International Reports (2025-01-01)Get full text
Article -
2
-
3
-
4
Trends in the proportion of women as reviewers, editors, and editorial board members of 15 North American and British medical journals from 2014 to 2019: A retrospective study by Roxanna Wang, Robin Roberts, James C Fredenburgh, Mary Cushman, Jeffrey I Weitz
Published in European Science Editing (2022-07-01)Get full text
Article -
5
-
6
P839: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN SHOW IMPROVEMENTS IN D-DIMER NORMALIZATION AND DECREASE IN INCIDENCE OF THROMBOSIS by I. Weitz, M. Al-Adhami, J. Min, E. Persson, M. Yeh, J. Savage, D. Dingli
Published in HemaSphere (2022-06-01)Get full text
Article -
7
Fibrous hydrogels under biaxial confinement by Yang Li, Yunfeng Li, Elisabeth Prince, Jeffrey I. Weitz, Sergey Panyukov, Arun Ramachandran, Michael Rubinstein, Eugenia Kumacheva
Published in Nature Communications (2022-06-01)Get full text
Article -
8
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin by Kochawan Boonyawat, Anthonie W. A. Lensing, Martin H. Prins, Jan Beyer‐Westendorf, Paolo Prandoni, Ida Martinelli, Saskia Middeldorp, Akos F. Pap, Jeffrey I. Weitz, Mark Crowther
Published in Research and Practice in Thrombosis and Haemostasis (2021-02-01)Get full text
Article -
9
Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study by Vincent ten Cate, Anthonie W.A. Lensing, Jeffrey I. Weitz, Jan Beyer-Westendorf, Philip S. Wells, Patrick Mismetti, Paolo Prandoni, Alexander T. Cohen, Bruce L. Davidson, Martin H. Prins
Published in Haematologica (2019-10-01)Get full text
Article -
10
The contact activation system as a potential therapeutic target in patients with COVID‐19 by Joseph J. Shatzel, Emma P. DeLoughery, Christina U. Lorentz, Erik I. Tucker, Joseph E. Aslan, Monica T. Hinds, David Gailani, Jeffrey I. Weitz, Owen J. T. McCarty, Andras Gruber
Published in Research and Practice in Thrombosis and Haemostasis (2020-05-01)Get full text
Article -
11
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13 by Hasam Madarati, Veronica DeYoung, Kanwal Singh, Taylor Sparring, Andrew C. Kwong, James C. Fredenburgh, Cherie Teney, Marlys L. Koschinsky, Michael B. Boffa, Jeffrey I. Weitz, Colin A. Kretz
Published in Scientific Reports (2024-04-01)Get full text
Article -
12
Risk of recurrent venous thromboembolism according to baseline risk factor profiles by Martin H. Prins, Anthonie W.A. Lensing, Paolo Prandoni, Philip S. Wells, Peter Verhamme, Jan Beyer-Westendorf, Rupert Bauersachs, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Bruce L. Davidson, Hervé Decousus, Ajay K. Kakkar, Bonno van Bellen, Akos F. Pap, Martin Homering, Miriam Tamm, Jeffrey I. Weitz
Published in Blood Advances (2018-04-01)Get full text
Article -
13
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease by Sylvia Haas, Alfredo E. Farjat, Karen Pieper, Walter Ageno, Pantep Angchaisuksiri, Henri Bounameaux, Samuel Z. Goldhaber, Shinya Goto, Lorenzo Mantovani, Paolo Prandoni, Sebastian Schellong, Alexander G.G. Turpie, Jeffrey I. Weitz, Peter MacCallum, Hugo ten Cate, Elizaveta Panchenko, Marc Carrier, Carlos Jerjes-Sanchez, Harry Gibbs, Petr Jansky, Gloria Kayani, Ajay K Kakkar
Published in TH Open (2022-10-01)Get full text
Article
